To develop and evaluate a digital patient decision aid (PDA) called OptiWeight, tailored for antiobesity medications (AOMs) in Taiwanese clinical settings, addressing specific patient needs.
Key Findings:
OptiWeight was designed to enhance shared decision-making by presenting treatment options for AOMs in a user-friendly manner, with usability testing revealing specific navigation and content organization issues that were subsequently addressed.
Interpretation:
The development of OptiWeight highlights the importance of tailored decision aids in improving patient engagement and decision-making in obesity treatment, particularly in underserved populations, by providing clear, accessible information.
Limitations:
The study was conducted in two medical centers, which may limit generalizability to other settings, and potential biases in participant selection should be considered.
Further evaluation is needed to assess the long-term impact of OptiWeight on decision-making and health outcomes.
Conclusion:
OptiWeight represents a significant advancement in providing patient-centered support for AOM selection, potentially leading to better treatment outcomes in obesity management and suggesting avenues for future research.
